Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / South Africa

Ranbaxy Agrees South African JV

February 2006 | Company Finance Alert

However, Ranbaxy is reported to have secured only one voluntary license to date. The Indian firm hopes that the deal willmark its re-entry to the market following withdrawals and quality issues. This reportedly led to the termination of it then joint venture with second-ranked local firm Adcock

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
MSD Grants Two More Efavirenz Licences

Companies / South Africa Merck Sharpe & Dohme (MSD), the international subsidiary of US-based Merck & Co has granted a further two licences for generic versions of its antiretroviral (ARV) Stocrin (efavirenz) in South...
June 2008
Old Mutual SA And Lethimvula Look To Merge

Companies / South Africa Old Mutual South Africa (OMSA) has signed a memorandum of understanding with Lethimvula Investments that would see the merger of their respective healthcare interests to form South Africa's largest medical...
May 2008
Enaleni Rose To The Challenge In 2007

Companies / South Africa In the company's own words, Enaleni's recently released annual results for the year ending December 31 2007 were 'reasonable, under the circumstances'. BMI would agree with this assessment. Revenues...
March 2008
Tiger Brands Acquires Local OTC Firm

Companies / South Africa South African healthcare group Tiger Brands is to acquire local consumer health company Designer Group Holdings for an undisclosed fee. The purchase, which is subject to approval by the Competition Board,...
September 2006
Lupin To Form Joint Venture With Aspen

Companies / South Africa Indian drugmaker Lupin has agreed a deal with South African generics firm Aspen to form a 50:50 joint venture to develop, manufacture and market TB drugs. The JV will also investigate the possibilities...
March 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS